Shanghai Kaibao Pharmaceutical CO.,Ltd (SHE:300039)
China flag China · Delayed Price · Currency is CNY
6.53
+0.02 (0.31%)
Feb 27, 2026, 3:04 PM CST

SHE:300039 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
6,8306,4646,9568,4316,4435,094
Market Cap Growth
8.29%-7.07%-17.49%30.84%26.49%-2.79%
Enterprise Value
5,1965,1456,2246,8285,0423,721
Last Close Price
6.536.056.407.695.834.58
PE Ratio
19.7617.2121.2244.1945.9948.00
Forward PE
-24.1524.1524.1524.1524.15
PS Ratio
5.834.394.367.545.865.61
PB Ratio
1.501.581.732.242.121.98
P/TBV Ratio
1.561.641.752.272.162.03
P/FCF Ratio
33.8746.7019.6724.4577.1421.52
P/OCF Ratio
30.8323.1718.1822.4051.1120.32
PEG Ratio
-0.970.970.970.970.97
EV/Sales Ratio
4.443.493.916.104.584.10
EV/EBITDA Ratio
15.1713.1817.9232.0232.9130.80
EV/EBIT Ratio
16.8314.5020.0937.6242.2546.51
EV/FCF Ratio
25.7637.1717.6019.8060.3615.72
Debt / Equity Ratio
0.000.00---0.01
Debt / EBITDA Ratio
0.010.01---0.30
Debt / FCF Ratio
0.020.04---0.15
Net Debt / Equity Ratio
-0.36-0.41-0.19-0.22-0.48-0.55
Net Debt / EBITDA Ratio
-4.78-4.34-2.16-3.90-9.49-11.77
Net Debt / FCF Ratio
-8.11-12.23-2.13-2.41-17.41-6.01
Asset Turnover
0.250.320.360.290.350.32
Inventory Turnover
1.141.521.881.521.310.95
Quick Ratio
11.079.493.864.7210.858.50
Current Ratio
12.3910.404.415.3211.829.35
Return on Equity (ROE)
8.21%9.22%8.39%5.59%4.98%4.12%
Return on Assets (ROA)
4.15%4.88%4.38%2.98%2.39%1.75%
Return on Invested Capital (ROIC)
10.13%10.76%8.50%6.75%7.18%5.35%
Return on Capital Employed (ROCE)
6.50%8.30%7.30%4.60%3.80%3.00%
Earnings Yield
5.06%5.81%4.71%2.26%2.17%2.08%
FCF Yield
2.95%2.14%5.08%4.09%1.30%4.65%
Dividend Yield
0.92%1.65%1.56%0.78%0.86%0.66%
Payout Ratio
30.28%27.85%19.14%27.41%22.59%98.56%
Buyback Yield / Dilution
0.01%-0.00%0.02%-0.01%-0.04%1.31%
Total Shareholder Return
0.95%1.65%1.59%0.77%0.81%1.97%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.